Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05811377 · ClinicalTrials.gov registry record · Early Phase 1
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
A Early Phase 1 study of IC - Interstitial Cystitis, sponsored by Christopher J Chermansky, MD.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05811377 is a Early Phase 1 study of IC - Interstitial Cystitis that has completed, run by Christopher J Chermansky, MD. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05811377, a Early Phase 1 study of IC - Interstitial Cystitis, has completed, sponsored by Christopher J Chermansky, MD.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Each participant will be asked to participate in this research study which distinguishes different types of Interstitial Cystitis/Bladder Pain Syndrome. Research studies include only people who wish to participate. The study team members will explain the study to each participant, and all questions about the study will be answered. Each participant will be given adequate time when deciding to participate in this study. Should the participant consent to participate, then the participant will agree to undergo have a single Magnetic Resonance Imaging (MRI) test that involves the use of radio waves and a powerful magnet which are linked to a computer that looks at the bladder. The MRI test is being performed to see if the bladder is leaky, which would suggest Interstitial Cystitis (IC). The MRI test involves placing Gadobutrol and Ferumoxytol into the bladder using a sterile catheter, a small hollow tube through which fluids pass. Preliminary data suggests that IC patients with Hunners lesions have increased Gadobutrol in the bladder wall lining.
Conditions Studied
Interventions
- DRUG Ferumoxytol
- DRUG Gadobutrol
Study Locations (1)
Pennsylvania
- UPMC Magee Women's Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2025-05-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05811377
The ClinicalTrials.gov registry entry for NCT05811377 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher J Chermansky, MD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with IC - Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Ferumoxytol is the first listed.
NCT05811377 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05811377 about?
NCT05811377 is a clinical study titled "Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay". Each participant will be asked to participate in this research study which distinguishes different types of Interstitial Cystitis/Bladder Pain Syndrome. Research studies include only people who wish to participate. The study team members will explain the study to each participant, and all questions ...
What is the current status of trial NCT05811377?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2023-03-29. Estimated completion is 2025-05-20.
What conditions does trial NCT05811377 study?
This clinical trial studies the following conditions: IC - Interstitial Cystitis.
What interventions are being tested in trial NCT05811377?
The interventions under investigation include: Ferumoxytol (DRUG), Gadobutrol (DRUG).
Who is sponsoring clinical trial NCT05811377?
This trial is sponsored by Christopher J Chermansky, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05811377 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.